Gland Pharma shares surge seven percent to fifty-two week high despite market drop
Gland Pharma stock climbed to a new fifty-two week peak, rising seven percent despite a broader market sell-off. The pharmaceutical company opened higher at ₹3,147 on the National Stock Exchange (NSE) compared to its previous close of ₹3,132.80, eventually hitting an intraday peak of ₹3,352 on November 9.
Open for the full story →